相关实验视频
Updated: Jan 22, 2026

06:36
Lower Limb Biomechanical Analysis of Healthy Participants
Published on: April 15, 2020
9.6K
埃法维伦兹和CYP2C9遗传多态性减少了健康参与者的CYP2C9活性
Jason D Kim1, Ingrid F Metzger1,2, Jessica Bo Li Lu1
1Division of Clinical Pharmacology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Clinical and translational science
|January 20, 2026
概括
长期使用埃法维伦兹会抑制细胞染色体P450 2C9 (CYP2C9) 的活体活性,从而增加托尔布塔米德水平. 这种药物相互作用需要对患者进行监测和剂量调整 efavirenz 和 CYP2C9 基质.
科学领域:
- 药理学 药理学是指药理学的学科.
- 药物新陈代谢 药物新陈代谢
- 临床药理学 临床药理学
背景情况:
- 细胞染色体P450 2C9 (CYP2C9) 对于各种药物的代谢至关重要.
- 埃法维伦兹是一种抗逆转录病毒药物,具有潜在的药物相互作用 (DDI) 影响.
- 埃法维伦兹在体内对CYP2C9活性的影响以前没有被描述.
研究的目的:
- 为了研究慢性埃法维伦兹剂量对人类CYP2C9活性的影响.
- 评估 efavirenz-CYP2C9 药物相互作用 (DDI) 的临床意义.
主要方法:
- 一个临床DDI研究使用托尔布塔胺作为CYP2C9.9的探针基质.
- 健康的参与者接受了单剂 (SD) 和多剂 (MD) 的 efavirenz.
- 用CYP2C9基因定型对托尔布塔米德及其代谢物的药理动力学分析.
主要成果:
- 多剂量埃法维伦兹显著增加了托尔布胺的暴露 (AUC) 超过50% (p < 0.0001).
- 埃法维伦兹降低了托尔布胺的清除和代谢物形成.
- CYP2C9遗传变异影响了托尔布胺的消除,尽管基因型特异性的DDI效应受到样本大小的限制.
结论:
- 长期服用埃法维伦兹会在体内抑制CYP2C9的活性.
- 这种抑制对服用狭窄治疗指数CYP2C9基质的患者构成风险.
- 治疗药物监测和剂量调整建议在联合服用 efavirenz 和 CYP2C9 基质,如华法林.
相关概念视频
Single Nucleotide Polymorphisms-SNPs
18.0K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
18.0K
Genetics of Speciation
20.9K
Speciation is the evolutionary process resulting in the formation of new, distinct species—groups of reproductively isolated populations.
20.9K
Reducing Line Loss
370
In a three-phase circuit, line loss is an indicator of energy dissipated as heat due to the resistance of transmission lines. To address this, incorporating transformers into the system—a step-up transformer at the source and a step-down transformer at the load—is a strategic solution. Two three-phase transformers are introduced to improve this.
With a step-up transformer at the source, the voltage is increased, thereby reducing the current in the transmission lines since power loss in...
With a step-up transformer at the source, the voltage is increased, thereby reducing the current in the transmission lines since power loss in...
370
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
679
Polymorphism refers to the existence of a drug substance in multiple crystalline forms, known as polymorphs. Recently, this term has been expanded to include solvates (forms containing a solvent), amorphous forms (non-crystalline forms), and desolvated solvates (forms from which the solvent has been removed).
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
679
What is Population Genetics?
64.5K
A population is composed of members of the same species that simultaneously live and interact in the same area. When individuals in a population breed, they pass down their genes to their offspring. Many of these genes are polymorphic, meaning that they occur in multiple variants. Such variations of a gene are referred to as alleles. The collective set of all the alleles within a population is known as the gene pool.
64.5K
What is Genetic Engineering?
79.7K
Overview
79.7K

